In the practice of oncology, and even in sub-specialties such as the care of women with breast cancer, it can be challenging and sometimes overwhelming to keep up to date with the latest discoveries and publications. In the past few years, the review article [1, 2] was the standard vehicle for keeping up to date for most clinicians. Review articles of this type, while often excellent summations of the available data, did not use explicit criteria for the inclusion or weighting of evidence from articles which often had wide variability in methodologic quality. Furthermore, today’s methods of rapid computer-based formalized literature retrieval were not available at that time. In spite of that limitation, however, published articles were usually accessible using hand searching methods which are still an important part of all literature reviews and guideline productions [3–5]. More problematic in such reviews was the lack of access to unpublished material, since review articles and indeed even consensus documents, guidelines and meta-analyses of published data do not usually attempt to retrieve such data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Henderson IC, Canellos GP. Cancer of the breast: The past decade (first of two parts). N Engl J Med. 1980;302:17–30.
Henderson IC, Canellos GP. Cancer of the breast: The past decade (second of two parts). N Engl J Med. 1980;302:78–90.
Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995;13:502–12.
Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: An overview of 61 randomized trials among 28,896 women. N Engl J Med. 1988;319:1681–92.
Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;365:1687–717.
De Angelis C, Drazen JM, Frizelle F, et al. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. Ann Intern Med. 2004;141:477–8.
Tam VC, Hotte SJ. Consistency of phase III clinical trials abstracts presented at an annual meeting of the American Society of Clinical Oncology compared with their subsequent full-text publications. J Clin Oncol. 2008;26:2205–11.
Chalmers TC, Matta R.J., Smith H Jr, Kunzler AM. Evidence favouring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Eng J Med. 1977;297:1097.
Rosenthal R. Combining results of independent studies. Psych Bulletin. 1978;85:185–93.
Goldman L, Feinstein AR. Angicoagulants and myocardial infarction: The problems of pooling, drowning and floating. Ann Inter Med. 1979;90:92–4.
Delozier T, Juret P, Couette JE, Mace-Lesech J. Ovarian irradiation in postmenopausal women with breast cancer and positive axillary nodes. In: Early Breast Cancer Trialists' Collaborative Group, ed. Treatment of Early Breast Cancer. Worldwide Evidence 1985–1990. A Systematic Overview of all Available Randomized Trials of Adjuvant Endocrine and Cytoxic Therapy. Oxford: Oxford University Press; 1990:114.
Pritchard KI. Ovarian ablation as adjuvant therapy for premenopausal women with early breast cancer: Phoenix arisen? (Editorial). Lancet. 1992;339:95–6.
Early Breast Cancer Trialists' Collaborative Group. Ovarian ablation in early breast cancer: An overview of the randomized trials. Lancet. 1996;348:1189–96.
Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet. 1998;351:1451–67.
Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet. 1998;352:930–42.
Personal communication with Sir Richard Peto. 2008.
Ingle JN, Dowsett AG, Cuzick J, Davies C, Early Breast Cancer Trialists' Collaborative Group. Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: Meta-analysis of randomized trials of monotherapy and switching strategies. Br Cancer Res Treat. 2008;106. Abstract 107.
Peto R, Davies C. ATLAS (Adjuvant Tamoxifen, Longer Against Shorter): international randomized trial of 10 versus 5 years of adjuvant tamoxifen among 11 500 women preliminary results [abstract]. Br Cancer Res Treat. 2007;106.Abstract 48.
Earl H, Gray R, Kerr D, Lee M. The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: Randomize into ATom. Clin Oncol (R Coll Radiol). 1997;9:141–43.
Abrams JS, Eifel P. Monograph Overview. Monogr Natl Cancer Inst. 2001;30:1–4.
Office the Director NIH. Guidelines for the planning and management of NIH Consensus Development Conferences. NIH. 1993. Report http://consensus.nih.gov
Moxley JH, Allegra JC, Henney J, Muggia FM. Treatment of primary breast cancer: Summary of the National Institutes of Health Consensus Development Conference. JAMA. 1980;244:797–803.
Consensus Conference. Adjuvant chemotherapy for breast cancer. JAMA. 1985; 254:3461–3.
NIH Consensus Conference. Treatment of early stage breast cancer. JAMA. 1991;265:391–5.
National Institutes of Health Consensus Development Panel. The National Institutes of Health Consensus Development Conference: Adjuvant therapy for breast cancer. J Natl Cancer Inst. 2001;30:1–152.
National Institutes of Health Consensus Panel. National Institiutes of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst. 2001;93:979–89.
Bryant J., Fisher B, Dignam J. Duration of Adjuvant Tamoxifen Therapy. J Natl Cancer Inst. 2001;30:56–61.
Davidson N.E. Ovarian ablation as adjuvant therapy for breast cancer. J Natl Cancer Inst. 2001;30:67–71.
Balaban EP, Brouwers M, Temin SB, Lyman GH. Issues in clinical practice guideline implementation and utilization. ASCO Educational Book. In press 2009.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pritchard, K.I. (2009). Guidelines, Consensus Conferences and Overviews (Meta-analysis). In: Castiglione, M., Piccart, M. (eds) Adjuvant Therapy for Breast Cancer. Cancer Treatment and Research, vol 151. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75115-3_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-75115-3_5
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-75114-6
Online ISBN: 978-0-387-75115-3
eBook Packages: MedicineMedicine (R0)